and the comparison between them was statistically significant ( P value = 0.04)
But even after this drop, its common for weight to return once the medication is stopped, as the body gradually shifts toward its usual patterns
PRICING For Medical Weight Loss, we begin with a Wellness Consult and Lab Draw at our office in Kansas City to help you start looking and feeling your best
Starting with smaller amounts can help them feel more comfortable at first

Study Strengths & Limitations Strengths: Large, international, double-blind RCT with adjudicated endpoints Comprehensive, repeated adiposity measures using standardised protocols Sophisticated statistical handling including multiple imputation models for missing data Pre-specified analysis with clear hypotheses Limitations: Predominantly White (77%) and male (63%) cohortgeneralisability to other populations requires confirmation Industry-funded (Novo Nordisk), though with independent academic oversight Post-randomisation analyses of weight/waist changes are observational and cannot prove causation The paradoxical association in placebo between weight loss and increased MACE suggests unintentional weight loss from comorbiditya key confounder The Bottom Line for Clinicians Semaglutide provides robust cardiovascular protection in patients with obesity and established CVD, independent of baseline adiposity and largely independent of weight-loss magnitude

Instead of following a fixed schedule to 2.4mg, your provider evaluates your weight loss rate, appetite suppression quality, side effect severity, and overall well-being at each dose level